Extract

The primary objective is to estimate the relative and absolute effects of antithrombotic drugs on the risk of recurrent symptomatic ICH associated with a policy of starting antithrombotic drugs after the acute phase of spontaneous ICH.

Inclusion criteria

• We want to study patients with indication for antithrombotic drugs who suffers from spontaneous intracerebral hemorrhage (ICH). It has long been unclear whether survivors of ICH should start antithrombotic drugs for continued secondary prevention of vaso-occlusive disease or avoid antithrombotic drugs in case it increases the risk of intracerebral hemorrhage

Links

• euctr